Bladder Cancer Outcomes at KFSYSCC
Between 2015-2019, the five-year survival rate for bladder cancer at KFSYSCC was 84.6%.
Basic Information and Stage Distribution of 918 Bladder Cancer Patients at KFSYSCC from 1990-2019
| Total | 1990-1994 | 1995-1999 | 2000-2004 | 2005-2009 | 2010-2014 | 2015-2019 | |
|---|---|---|---|---|---|---|---|
| n | 918 | 13 (1%) | 65 (7%) | 183 (20%) | 230 (25%) | 226 (25%) | 201 (22%) |
| Gender (%) | |||||||
| Male | 665 (72%) | 9 (69%) | 50 (77%) | 131 (72%) | 158 (69%) | 169 (75%) | 148 (74%) |
| Female | 253 (28%) | 4 (31%) | 15 (23%) | 52 (28%) | 72 (31%) | 57 (25%) | 53 (26%) |
| Age | |||||||
| Mean/Median | 64/64 | 58/57 | 65/66 | 63/63 | 63/64 | 63/63 | 65/64 |
| Range | 28-96 | 42-76 | 28-96 | 29-92 | 30-87 | 35-92 | 36-92 |
| Q1-Q3 | 55-72 | 50-67 | 58-73 | 54-72 | 54-72 | 55-73 | 58-74 |
| Stage (%) | |||||||
| 0 | 216 (24%) | 0 (0%) | 6 (9%) | 10 (5%) | 49 (21%) | 81 (36%) | 70 (35%) |
| I | 243 (26%) | 3 (23%) | 16 (25%) | 31 (17%) | 72 (31%) | 63 (28%) | 58 (29%) |
| II | 116 (13%) | 2 (15%) | 6 (9%) | 21 (11%) | 27 (12%) | 29 (13%) | 31 (15%) |
| III | 87 (9%) | 0 (0%) | 5 (8%) | 14 (8%) | 21 (9%) | 25 (11%) | 22 (11%) |
| IV | 100 (11%) | 3 (23%) | 6 (9%) | 25 (14%) | 31 (13%) | 18 (8%) | 17 (8%) |
| Unknown | 156 (17%) | 5 (38%) | 26 (40%) | 82 (45%) | 30 (13%) | 10 (4%) | 3 (1%) |
Based on KFSYSCC's cancer registry from 1990 to 2019, there were 918 analytic bladder cancer cases, with 665 males (72%) and 253 females (28%). The average and median ages were 64 and 64 years old, respectively; the youngest patient was 28 years old, and the oldest was 96 years old; the interquartile range (Q1-Q3) was 55-72. By stage, there were 216 stage 0 bladder cancer patients (24%), 243 stage I patients (26%), 116 stage II patients (13%), 87 stage III patients (9%), and 100 stage IV patients (11%). The basic information and stage distribution of all oral cancer patients, sorted by the year of diagnosis, are presented in the table above.
Survival Curves for 918 Bladder Cancer Patients (1990-2019), Stratified by Year of Diagnosis
From 1990 to 2019, the chart illustrates the five-year observed survival rates for 918 bladder cancer patients at KFSYSCC, stratified by the year of diagnosis. The graph shows the five-year survival rate for bladder cancer decreased from 85% in 1990-1994 to 72% in 2015-2019, while the ten-year survival rate rose from 62% in 1990-1994 to 65% in 2010-2014.
Treatment Methods and Stages for 4,088 Breast Cancer Patients
at KFSYSCC (2015-2019)
| Category | Total | Stage 0 | Stage I | Stage II | Stage III | Stage IV | Unknown |
|---|---|---|---|---|---|---|---|
| Total | 201 | 70 | 58 | 31 | 22 | 17 | 3 |
| Surgical Treatment | 195 (97%) | 69 (99%) | 57 (98%) | 31 (100%) | 22 (100%) | 13 (76%) | 3 (100%) |
| Radiation Therapy | 5 (2%) | 0 (0%) | 0 (0%) | 4 (13%) | 0 (0%) | 0 (0%) | 1 (33%) |
| Chemotherapy | 161 (80%) | 61 (87%) | 54 (93%) | 16 (52%) | 15 (68%) | 13 (76%) | 2 (67%) |
| Immunotherapy | 25 (12%) | 5 (7%) | 17 (29%) | 1 (3%) | 1 (5%) | 1 (6%) | 0 (0%) |
| Palliative Care | 3 (1%) | 0 (0%) | 0 (0%) | 0 (0%) | 1 (5%) | 2 (12%) | 0 (0%) |
Between 2015 and 2019, there were a total of 4,088 analytic breast cancer cases, including 525 patients in stage 0, 1,384 in stage I, 1,336 in stage II, 637 in stage III, and 186 in stage IV. In terms of treatment methods, 3,896 patients (95%) underwent surgical treatment, 2,725 (67%) received radiation therapy, 2,444 (60%) underwent chemotherapy, 658 (16%) received hormone therapy, 2,612 (64%) underwent immunotherapy, 58 (1%) received palliative care, and 1 (0.02%) had no record of initial treatment reported.
Five-Year Survival Rates of 201 Bladder Cancer Patients by Stage (2015-2019)
KFSYSCC’s 2015-2019 five-year observed survival rates for 201 bladder cancer patients, stratified by stage, are presented in this chart. As shown in the graph, the five-year survival rate is 94% for stage 0, 69% for stage 1, 58% for stage 2, 45% for stage 3, and 46% for stage 4.